Project Grant RM1MH138309
Award Date
1/15/25
Completion Date
11/30/29
Dollars Obligated
$3.5M
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $911,929 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the Scripps Research Institute in La Jolla, CA to conduct scalable functional analysis of neuropsychiatric risk genes using spatially integrated in vivo perturb-seq technology. This 5-year research project aims to comprehensively map the functions of 72 high-confidence autism spectrum disorder and neurodevelopmental delay (ASD/NDD) risk genes in the neocortex and...
This federal Project Grant award for $727,248.00, awarded on September 25, 2024 by the National Institute of Mental Health (NIMH) under CFDA 93.242 Mental Health Research Grants, supports research to investigate how mutations in the Neurexin1 (NRXN1) gene contribute to goal-directed dysfunction across neuropsychiatric disorders. The key objectives are to: 1) Mechanistically examine how NRXN1 functions within midbrain dopamine neurons and striatal cholinergic interneurons to alter striatal...
The National Institute of Mental Health (NIMH) awarded a 5-year, $2,462,651 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Washington University in St. Louis. The grant will fund a systematic and scalable phenotyping effort to investigate the impact of prioritized genetic mutations known to cause neurodevelopmental and psychiatric disorders using over 100 mouse lines. Through behavioral analysis, anatomical mapping, and molecular assessments, the project...
The National Institute of Mental Health (NIMH) awarded a $702,928 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The Trustees of the University of Pennsylvania to conduct research on the shared neural basis and genetic architecture of psychiatric disorders. The project aims to integrate multi-organ imaging data, psychiatric genetic studies, and functional genomic data to enhance understanding of the complex genetic underpinnings of mental health conditions. By analyzing common...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $742,484 to the University of Alabama at Birmingham (UAB) to conduct functional studies on a gene implicated in neurodevelopmental disorders such as autism, intellectual disability, and schizophrenia. The research will characterize a genetic mouse model to delineate the gene's function in the brain, including obtaining multiome single nucleus...
This three-year, $3.456 million project grant from the National Institute of Mental Health (NIMH) Mental Health Research Grants program (CFDA 93.242) will fund research into the role of microglia in neurodevelopmental disorders. The grantee, Cold Spring Harbor Laboratory, will merge two-photon imaging of microglia and synapses in the brains of live mice with single-cell genomics and CRISPR screens. This will help define microglia's role in experience-dependent synaptic refinement, a process...
This Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242 Mental Health Research Grants provides $1,096,486.32 to New York University (NYU) to support a 3-year research project investigating the transcriptional basis of stereotyped neural architectures. The key objectives are to: Elucidate the genetic programs responsible for the formation and maintenance of neural architectures in the nervous systems of Caenorhabditis elegans and the rodent hippocampus. This...
The National Institute of Mental Health (NIMH) awarded a Project Grant (CFDA 93.242 - Mental Health Research Grants) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop statistical methods for fine-mapping causal genetic variants associated with psychiatric disorders across diverse ancestral populations. The $129,288 award, effective from August 1, 2024 to July 31, 2026, will fund the research and development of three key products: A...
This $535,153 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a large-scale, single-cell characterization of molecular and cellular networks of mood regulation circuitry in major depressive disorder (MDD). The research aims to: 1) identify transcriptomic changes associated with MDD at the single-cell level across three brain regions (anterior cingulate cortex, basolateral amygdala, and hippocampus),...
This federal Project Grant award of $714,615 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to dissect the regulatory mechanisms of a genetic risk locus for schizophrenia and bipolar disorder. The principal research activities include: Fine mapping regulatory features of a human-specific repeat expansion within the CACNA1C gene using long-read methyltransferase accessibility profiling (fiber-seq). Applying a...